z-logo
Premium
DLX genes as targets of ALL ‐1: DLX 2,3,4 down‐regulation in t(4;11) acute lymphoblastic leukemias
Author(s) -
Ferrari Nicoletta,
Palmisano Giulio L.,
Paleari Laura,
Basso Giuseppe,
Mangioni Manuela,
Fidanza Vincenzo,
Albini Adriana,
Croce Carlo M.,
Levi Giovanni,
Brigati Claudio
Publication year - 2003
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1102581
Subject(s) - biology , gene , lymphoblastic leukemia , genetics , computational biology , leukemia
Dlx genes constitute a gene family thought to be essential in morphogenesis and development. We show here that in vertebrate cells, Dlx genes appear to be part of a regulatory cascade initiated by acute lymphoblastic leukemia (ALL)‐1, a master regulator gene whose disruption is implicated in several human acute leukemias. The expression of Dlx2 , Dlx3 , Dlx5 , Dlx6 , and Dlx7 was absent in All‐1 −/− mouse embryonic stem cells and reduced in All‐1 +/− cells. In leukemic patients affected by the t(4;11)(q21;q23) chromosomal abnormality, the expression of DLX 2, DLX 3, and DLX 4 was virtually abrogated. Our data indicate that Dlx genes are downstream targets of ALL‐1 and could be considered as important tools for the study of the early leukemic cell phenotype.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here